FDA Drug recall D-0870-2023
GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 51662-1487-3
- FDA Drug
- Class III
- terminated
- Published 2023-06-14
On 2023-06-14 the FDA classified a Class III recall of GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 51662-1487-3 by Hf Acquisition, citing labeling: Label Mix-up.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0870-2023 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2023-06-06 |
| Published | 2023-06-14 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Hf Acquisition |
| Distribution | AZ, CA, TX |
Product
GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 51662-1487-3
Reason
Labeling: Label Mix-up
Identifiers
| ndc | 51662-1487-1 |
|---|---|
| ndc | 51662-1487-2 |
| ndc | 51662-1487-3 |
| code_info | Lot #: 2205095.1, Exp. Date 7/31/2024 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0870-2023%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.